Mylan Launches Generic Crestor(R) Tablets

HERTFORDSHIRE, England and PITTSBURGH, July 20, 2016 -- (Healthcare Sales & Marketing Network) -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Rosuvastatin Calcium Tablets, 5 mg, 10 mg, 20 mg and 40 mg, which is a generic version of A... Biopharmaceuticals, Generics, FDA, Product LaunchMylan, Rosuvastatin, Crestor, AstraZeneca
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news